Abstract
Background Aortic stenosis (AS) has been associated with sleep-disordered breathing (SDB), obstructive sleep apnea (OSA), and central sleep apnea (CSA). In patients undergoing transcatheter aortic valve implantation (TAVI), CSA may contribute to sudden cardiac death. Knowledge regarding complications and management of patients with TAVI and CSA is limited. This review defines the clinical manifestations of SDB, especially CSA, associated with AS and TAVI therapy. Prevalence, mechanisms, risk factors, and treatment options are reported.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
